Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro. (Q51321430)
Jump to navigation
Jump to search
scientific article published on 4 June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro. |
scientific article published on 4 June 2014 |
Statements
1 reference
Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro. (English)
1 reference
Julio Rosenstock
1 reference
Bo Ahrén
1 reference
Vivian A Fonseca
1 reference
Jorge L Gross
1 reference
Robert E Ratner
1 reference
Francis C C Chow
1 reference
Fred Yang
1 reference
Diane Miller
1 reference
Susan L Johnson
1 reference
Murray W Stewart
1 reference
Lawrence A Leiter
1 reference
Harmony 6 Study Group
1 reference
4 June 2014
1 reference
1 reference
37
1 reference
2317-2325
1 reference
8
1 reference
Identifiers
1 reference
1 reference